了解影响黑人医学学生入学和坚持学习的因素
Krista D Mincey1, Briana S L Richardson2, Raymond O Johnson3
1Department of Community Medicine, Mercer University School of Medicine, Macon, GA, United States.
Frontiers in medicine
|June 5, 2023
概括
黑人医学学生 黑人医学学生
科学领域:
- 医学教育 医学教育
- 医学中的多样性 医学中的多样性
- 健康 公平 卫生 公平
背景情况:
- 种族主义和教育机会不平等等系统性障碍影响了学术医学中的多样性.
- 美国医学院协会 (AAMC) 战略计划强调需要解决这些障碍.
研究的目的:
- 确定影响黑人医学学生入学和坚持学习的因素.
- 为提高医学院黑人学生入学和毕业率的战略提供信息.
主要方法:
- 使用Tinto的机构离开模型进行定性现象学研究.
- 进行了40次深入的,半结构化的采访,与16多所美国/加勒比医学院的黑人医学学生进行了深入的,半结构化的采访.
主要成果:
- 入学受到药物暴露和财务资源的影响.
- 受多样性影响的持久性,以及医学院内的情感和支持资源.
结论:
- 确定了五个关键因素,可以指导医学院提高黑人学生的招聘和留学率.
- 解决已识别的因素可以改善学术医学中的多样性.
相关概念视频
Factors affecting Blood pressure
3.4K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Physiological Factors:
3.4K
Factors Affecting Illness
4.3K
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
For instance, risk factors are connected to illness,...
4.3K
Longitudinal Research
12.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.0K
Factors Affecting Drug Distribution: Physiological Barriers
261
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
261
Factors Affecting Drug Distribution: Miscellaneous Factors
399
Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
399
Factors Influencing Drug Absorption: Presystemic Elimination
269
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
269


